Matt Willemsen<p>Meta-Analysis of Postcancer Use of Immunosuppressive Therapies Shows No Increase in Cancer Recurrence Risk<br>Patients with immune-mediated diseases and a history of malignancy had similar rates of cancer recurrence whether or not they were receiving immunosuppressive treatments<br><a href="https://www.medscape.com/s/viewarticle/998366" rel="nofollow noopener noreferrer" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">medscape.com/s/viewarticle/998</span><span class="invisible">366</span></a> <a href="https://fedibird.com/tags/MetaAnalysis" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>MetaAnalysis</span></a> <a href="https://fedibird.com/tags/Postcancer" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Postcancer</span></a> <a href="https://fedibird.com/tags/Immunosuppressive" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Immunosuppressive</span></a> <a href="https://fedibird.com/tags/Therapies" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Therapies</span></a></p>